High antagonist potency of GT-2227 and GT-2331, new histamine H3receptor antagonists, in two functional models

39Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

GT-2227 (4-(6-cyclohexylhex-cis-3-enyl)imidazole) and GT-2331 ((1R,2R)-4-(2-(5,5-dimethylhex-1-ynyl)cyclopropyl)imidazole) were developed as new potent histamine H3receptor antagonists. The functional activity of these ligands on the histamine H3receptor-mediated inhibition of neurogenic contraction of the guinea-pig jejunum and histamine H3receptor-mediated inhibition of norepinephrine release from guinea-pig heart synaptosomes were investigated. GT-2227 and GT-2331 both antagonized the inhibitory effects of (R)-α-methylhistamine on the contraction induced by electrical field stimulation in the guinea-pig jejunum with pA2values of 7.9±0.1 and 8.5±0.03, respectively. In addition, GT-2227 and GT-2331 antagonized the inhibition of norepinephrine release in cardiac synaptosomes by GT-2203 ((1R,2R)-trans-2-(1H-imidazol-4-yl)cyclopropylamine), a histamine H3receptor agonist. The current results demonstrate the antagonist activity for both GT-2227 and GT-2331 in two functional assays for histamine H3receptors. Copyright (C) 1998 Elsevier Science B.V. All rights reserved.

Cite

CITATION STYLE

APA

Tedford, C. E., Hoffmann, M., Seyedi, N., Maruyama, R., Levi, R., Yates, S. L., … Phillips, J. G. (1998). High antagonist potency of GT-2227 and GT-2331, new histamine H3receptor antagonists, in two functional models. European Journal of Pharmacology, 351(3), 307–311. https://doi.org/10.1016/S0014-2999(98)00396-3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free